Skip to main content
SunBio, Inc. logo

SunBio, Inc. — Investor Relations & Filings

Ticker · 067370 ISIN · KR7067370007 KO Manufacturing
Open in API
Filings indexed 213 across all filing types
Latest filing 2021-05-03 Report Publication Anno…
Country KR South Korea
Listing KO 067370

About SunBio, Inc.

http://www.sunbio.com/

SunBio, Inc. is a biotechnology company that develops biosimilars, biopharmaceuticals, and medical devices. The company's core activities are based on its proprietary PEGylation technology, a process that modifies molecules to enhance their therapeutic properties. SunBio's product portfolio includes PEG reagents for research and drug delivery, as well as biopharmaceutical candidates. Key development projects include MucoPEG™, a muco-adhesive hydrogel, and SBX, an artificial blood substitute. The company positions itself as a specialist in PEGylation, creating advanced therapeutic products for a global market.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) presentation. It specifies the date, time, location (online), and purpose of the event. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into specific categories like 'Call Transcript' or 'Annual Report', it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure notice.
2021-05-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. This type of filing is specifically used to disclose share ownership and changes in ownership by company insiders (directors/executives). In the provided taxonomy, 'Director's Dealing' (DIRS) is the category designated for reports of personal share transactions or ownership status by company directors and executives.
2021-04-15 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official report of the results of a General Meeting of Shareholders (AGM) for the company 'SunBio'. It details the outcomes of various agenda items, including the election of directors and auditors, and the approval of remuneration limits. While it mentions the postponement of financial statement approval, the document itself serves as the formal record of the meeting's proceedings and voting outcomes, which falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2021-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on the Granting of Stock Options) submitted to the Financial Services Commission/Korea Exchange. It details the issuance of stock options to employees and executives, including the number of shares, exercise price, and vesting conditions. This type of disclosure regarding the issuance of new equity-based compensation instruments falls under the category of 'Share Issue/Capital Change' (SHA) as it relates to the potential future issuance of shares and changes in capital structure.
2021-03-29 Korean
기타주요경영사항(자율공시)(사업보고서 등 지연제출에 대한 제재 면제 승인)
Report Publication Announcement Classification · 1% confidence The document is a short regulatory announcement (724 characters) regarding the approval of a delay in filing the annual report due to COVID-19. It does not contain the financial report itself but rather informs the market about a regulatory status change regarding filing deadlines. As it is a specific regulatory announcement that does not fit into the other specialized categories like M&A or Dividends, it falls under the general regulatory filing category.
2021-03-24 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for SunBio Co., Ltd. It includes details such as the meeting date, location, agenda items (financial statement approval, director appointments, etc.), and electronic voting procedures. It also contains supplementary information like board activity reports and business overviews, which are standard components of a proxy statement/notice of meeting in the Korean market. This document is a formal solicitation of shareholder votes and meeting information, fitting the definition of a Proxy Solicitation & Information Statement.
2021-03-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.